Vedolizumab for the Treatment of Collagenous Gastritis
Vedolizumab for the Treatment of Collagenous Gastritis
Active, not recruiting · NCT06317220 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vedolizumab for the Treatment of Collagenous Gastritis | collagenous gastritis | Active, not recruiting | Phase 2 | 2026-06-16 | NCT06317220 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Massachusetts General Hospital | 758 |
| Takeda | 163 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |